Valeant loses money in 1Q, cuts outlook, shares plunge

Valeant tumbled to a loss in its first quarter and the embattled drug maker, squeezed by higher costs, cut its profit and revenue expectations for the year

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s